NCT06940908 Living With Guillain-Barré Syndrome as Children.
| NCT ID | NCT06940908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Guillain Barré Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-05-05 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2025-05-05 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this qualitative observational study is to explore the lived experience and psychological aftermath of children who were affected by Guillain-Barré Syndrome (GBS) two to five years earlier. GBS is a rare and acute neurological condition, and while motor recovery is generally good in children, residual symptoms such as fatigue, pain, anxiety, or depression may persist and impact quality of life. The main questions it aims to answer are: How do children experience and recall their illness and recovery after GBS? What psychological or contextual factors might contribute to emotional distress or depressive symptoms in the years following the disease? Participants will: Be children aged 10 or older who had GBS two to five years prior. Participate in a 45-60-minute semi-structured individual interview during a routine follow-up visit. Respond to a screening questionnaire for depressive symptoms (Children's Depression Inventory or Beck Depression Inventory Fast Screen). Undergo a brief clinical examination to assess any remaining physical sequelae. Interviews will be audio recorded, transcribed verbatim, and pseudonymized. Thematic reflexive analysis will be performed following Braun and Clarke's methodology. Recruitment will continue until theoretical saturation is reached (approximately 25 participants expected) across two centers (Toulouse and Montpellier). This study aims to generate new insights into pediatric psychological outcomes after GBS, in order to improve acute care and follow-up, and potentially guide future mental health support for affected children.
Eligibility Criteria
Inclusion Criteria: * Children or adolescents aged 10 years or older at the time of the interview * History of Guillain-Barré syndrome (GBS) diagnosed in childhood * Time since acute episode: between 2 and 5 years * Sufficient mastery of the French language to participate in a semi-structured interview * Consent of the participant and, for minors, parental consent Exclusion Criteria: * Presence of a neurological disease other than GBS that may interfere with participation or interpretation of data * Severe cognitive impairment preventing the child or adolescent from engaging in the interview
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06940908 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Guillain Barré Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06940908 currently recruiting?
Yes, NCT06940908 is actively recruiting participants. Contact the research team at estublier.b@chu-toulouse.fr for enrollment information.
Where is the NCT06940908 trial being conducted?
This trial is being conducted at Montpellier, France, Toulouse, France.
Who is sponsoring the NCT06940908 clinical trial?
NCT06940908 is sponsored by University Hospital, Toulouse. The trial plans to enroll 25 participants.